Research programme: chlamydial infection therapies - Ricerca

Drug Profile

Research programme: chlamydial infection therapies - Ricerca

Alternative Names: Chlamydial infection therapies research programme - Ricerca

Latest Information Update: 07 Oct 2004

Price : $50

At a glance

  • Originator Ricerca Biosciences LLC
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Chlamydial infections

Most Recent Events

  • 07 Oct 2004 Discontinued - Preclinical for Chlamydial infections in USA (unspecified route)
  • 25 Oct 2002 Genset has been acquired by Serono
  • 01 Aug 2002 Preclinical trials in Chlamydial infections in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top